GLUL and Hyperammonemia: First of all, an NMDA receptor antagonist or GS inhibitor could be considered a therapeutic drug for hyperammonemia because the most established model of the working mechanism of ammonia toxicity is the activation of the NMDA receptor, which is initiated by the GS enzyme in astrocyte (Figure 3).